Q-Sense carries out a new share issue

Thursday, May 25, 2006

Q-Sense AB carries out a new share issue

Q-Sense has decided, at an extra shareholders' meeting on 30 September, to carry out a new issue of shares directed at present owners and employees.

The company's own cash funds are being strengthened with capital from NUTEK, employees and present owners - primarily Biolin Medical AB and AB Chalmersinvest - amounting to nearly 6 MSEK.

This additional capital is chiefly intended to finance the launching of the company's new product, a high-technology analytic instrument based upon the patented QCM-D technique. Today, demand for the instrument is high in academic research on materials technology and biomedicine. Supplementing the sales of the instrument is a stable and growing after-market of consumable articles.

Q-Sense has already installed eight prototypes in northern Europe. There is great international interest in the QCM-D technique, and Q-Sense has recently made a number of important contacts with immediate and potential customers especially in Finland, Germany and Great Britain. Currently, possibilities are also being investigated of establishing the company in the USA, where a large part of the company's market is situated.

For further information, please contact:
Bettina Wetterqvist, Q-Sense, tel +46-(0)31-772 80 41